Form 4: Privia Health CFO Sells Shares for Tax Obligations

Privia Health Group's EVP & CFO, David Mountcastle, reported a planned sale of 6,391 common shares at $22.11 each to cover tax withholding from performance stock unit vesting.

Summary

• David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc. (PRVA), reported a transaction involving the company's common stock.
• On March 16, 2026, Mountcastle sold 6,391 shares of common stock.
• The shares were sold at a price of $22.11 per share.
• The sale was a non-discretionary 'sell to cover' transaction, required to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
• Following this transaction, Mountcastle directly beneficially owns 220,413 shares and indirectly owns 8,695 shares through his spouse.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine, non-discretionary sale for tax purposes related to equity compensation, rather than a discretionary sale indicating a change in sentiment.

Positives

• The sale was non-discretionary and specifically for tax withholding purposes, not an indication of a lack of confidence in the company's future.
• The transaction was pre-planned under a Rule 10b5-1 plan, demonstrating a structured approach to insider trading compliance and transparency.

Negatives

• An insider sale, even for tax purposes, results in a reduction of the direct ownership stake held by a key executive.

Future Outlook

This Form 4 filing, being a report of an insider transaction, does not contain specific forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a standard practice for executives receiving equity compensation, particularly when performance stock units vest, and are generally not indicative of a change in management's outlook on the company's prospects. This is a routine compliance filing.

Comparison to Industry Standards

• This transaction aligns with common industry practices for executive compensation and tax management.
• Many executives at comparable healthcare technology companies, such as Teladoc Health (TDOC) or Amwell (AMWL), frequently engage in similar 'sell to cover' transactions upon the vesting of restricted stock units or performance shares to meet tax obligations, rather than funding these obligations out-of-pocket.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related sale, not a signal of executive sentiment regarding the company's prospects.
• Employees: No direct impact on employees from this specific transaction.

Key Dates

Recommendation

The transaction is a routine 'sell to cover' for tax obligations related to performance stock units, not a discretionary sale. It does not provide new information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Privia Health Group, PRVA, David Mountcastle, CFO, Insider Sale, Form 4, Stock Transaction, Tax Withholding, Performance Stock Units, 10b5-1 Plan